Therefore, if male ME/CFS patients and female HCs are able to efficiently regulate IL-12 production, this may suggest dysregulation of estrogen receptors in female ME/CFS patients as a potential driving force behind the observed difference in cytokine function. This evidence concerns the gene ESR1 and myalgic encephalomeyelitis/chronic fatigue syndrome.